Financial Results as per Regulation 33 of the SEBI (LODR) Reg, 2015
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Minute windows have no benchmark: there is no intraday index history to compare against.
Desh Rakshak Aushdhalaya Limited, a Haridwar-based Ayurvedic and herbal products manufacturer (BSE: 531521), reported unaudited results for Q3 FY26 (quarter ended Dec 2025) and nine months FY26. Total revenue for Q3 FY26 stood at ₹139.73 lakhs versus ₹189.97 lakhs in Q3 FY25, a YoY decline of about 26%. Nine-month revenue fell to ₹365.11 lakhs from ₹417.07 lakhs, down roughly 12.5%. Net profit for Q3 was ₹9.34 lakhs (vs ₹11.99 lakhs YoY) and ₹26.72 lakhs for 9M FY26 versus ₹35.78 lakhs in 9M FY25, a YoY decline of about 25%. Basic EPS for 9M FY26 came in at ₹0.47 versus ₹0.81 in the prior year period. The auditor (Anil Jain & Co.) issued a limited review report with an unmodified opinion, and there were no investor complaints pending.
Both top-line and bottom-line are lower year-on-year, which may weigh on the stock sentiment despite the clean auditor opinion. Shareholders should note the equity base expanded via a ₹2.77 crore preferential allotment (12.6 lakh shares at ₹22) completed in Sep 2025, which has been fully deployed for working capital and general corporate purposes with no deviation reported, resulting in EPS dilution.